Erlotinib intermediates manufacturer

2-Amino-4,5-bis(2-methoxyethoxy)benzonitrile
Tel: +86-311-67260775 sales@dingminpharma.com
Products

Lenvatinib

 

PRODUCT DESCRIPTION

 

Prodcut name

Lenvatinib

Synonyms

4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide

MOQ

1kg

CAS No.

417716-92-8

Appearance

White or off- white crystalline powder

Molecular Formula

C21H19ClN4O4

Molecular Weight

426.85

Assay

99%

Application

Pharma grade or research purpose

Packing

As per your request

Storage

Preserve in tight,light-resistant containers in a cool place

Remarks

NA

Custom synthesis

 Available

Supply Ability

50kg/month

 

Lenvatinib is an anti-cancer drug for the treatment of certain kinds of thyroid cancer, and potentially for other cancers as well. It was developed by Eisai Co. and acts as a multiple kinase inhibitor against the VEGFR1, VEGFR2 and VEGFR3 kinases.

 

SupplyAbility

100 Kilogram/Kilograms per Month

Packaging & Delivery

10g,100g, 1kg Aluminum Foil bag/25kg drum/ bottle or negotiation

Port

Any port in China

Lead Time :

within 3 working days after payment



Send your message to us
(* We will reply your inquiry to this Email as soon as we see it.)
Product:
Name: *
E-mail: *
Tel:
Message: *
Verification Code: *图片看不清?点击重新得到验证码
Other Products
PRODUCTS LIST
CONTACT US
Office Address: No.41, Zhaiying South Street, Yuhua District, Shijiazhuang, Hebei Province.Chinaa
R&D and Plant Address: Jinzhou Industry Park, Jinzhou County, Shijizhuang, Hebei Province.China
Tel: +86-311-67260775
Fax: +86-311-67591193
sales@dingminpharma.com
Online Service×